Brain stimulation for treatment-resistant voices in schizophrenia
Part of Mental health clinical trials.
This trial tests a brain stimulation treatment (rTMS) to help reduce the frequency and intensity of voices people with schizophrenia hear. It is for individuals who continue to hear voices frequently despite trying multiple medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have schizophrenia and your main problem is hearing voices that others don't.
- You still hear voices often (at least 10 times per hour) even after trying at least two different antipsychotic medications.
- Your medication dose for schizophrenia has not changed in the last 30 days.
- You are willing to have an MRI scan and do not have any metal or device in your body that would prevent it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a non-invasive brain stimulation method called transcranial magnetic stimulation (TMS) can reduce stubborn auditory hallucinations (hearing voices) in people with schizophrenia who haven't improved enough with medication.
This trial studies whether repeated noninvasive brain stimulation (TMS) can help reduce ongoing voice-hearing (auditory verbal hallucinations) in people with schizophrenia or schizoaffective disorder. It focuses on whether doing this after medication is already adjusted can improve symptoms and help keep them controlled.
This trial tests a targeted brain stimulation method (rTMS) using brain imaging to treat persistent auditory hallucinations that haven't improved with medication. It may help people with schizophrenia who continue to hear voices despite trying multiple antipsychotics.
This trial tests a type of brain stimulation called TMS to see if it can change brain connections that may be linked to symptoms. It might help people with schizophrenia or schizoaffective disorder who are stable on their current medications.
This trial tests whether a type of brain stimulation called TMS can help people with schizophrenia improve their ability to stop impulsive actions. By targeting the part of the brain that controls inhibition, researchers hope to reduce symptoms and improve daily functioning.
This study tests a brain stimulation treatment (neuromodulation) to improve brain connectivity in people with schizophrenia. It aims to see if this approach can help with symptoms and cognitive function.
Hear when a new Treatment Resistant Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.